280 related articles for article (PubMed ID: 16364194)
21. Expressing functional siRNAs in mammalian cells using convergent transcription.
Tran N; Cairns MJ; Dawes IW; Arndt GM
BMC Biotechnol; 2003 Nov; 3():21. PubMed ID: 14604435
[TBL] [Abstract][Full Text] [Related]
22. Antisense technologies. Improvement through novel chemical modifications.
Kurreck J
Eur J Biochem; 2003 Apr; 270(8):1628-44. PubMed ID: 12694176
[TBL] [Abstract][Full Text] [Related]
23. Recent developments in oligonucleotide conjugation.
Singh Y; Murat P; Defrancq E
Chem Soc Rev; 2010 Jun; 39(6):2054-70. PubMed ID: 20393645
[TBL] [Abstract][Full Text] [Related]
24. Oligonucleotide-based knockdown technologies: antisense versus RNA interference.
Achenbach TV; Brunner B; Heermeier K
Chembiochem; 2003 Oct; 4(10):928-35. PubMed ID: 14523910
[TBL] [Abstract][Full Text] [Related]
25. Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality.
Elmén J; Thonberg H; Ljungberg K; Frieden M; Westergaard M; Xu Y; Wahren B; Liang Z; Ørum H; Koch T; Wahlestedt C
Nucleic Acids Res; 2005; 33(1):439-47. PubMed ID: 15653644
[TBL] [Abstract][Full Text] [Related]
26. Oligonucleotide-based strategies to inhibit human hepatitis C virus.
Martinand-Mari C; Lebleu B; Robbins I
Oligonucleotides; 2003; 13(6):539-48. PubMed ID: 15025918
[TBL] [Abstract][Full Text] [Related]
27. Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA.
Mahato RI; Cheng K; Guntaka RV
Expert Opin Drug Deliv; 2005 Jan; 2(1):3-28. PubMed ID: 16296732
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic antisense and ribozymes.
Rossi JJ
Br Med Bull; 1995 Jan; 51(1):217-25. PubMed ID: 7767645
[TBL] [Abstract][Full Text] [Related]
29. RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts.
Grzelinski M; Urban-Klein B; Martens T; Lamszus K; Bakowsky U; Höbel S; Czubayko F; Aigner A
Hum Gene Ther; 2006 Jul; 17(7):751-66. PubMed ID: 16839274
[TBL] [Abstract][Full Text] [Related]
30. Small RNA: can RNA interference be exploited for therapy?
Wall NR; Shi Y
Lancet; 2003 Oct; 362(9393):1401-3. PubMed ID: 14585643
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic face of RNAi: in vivo challenges.
Borna H; Imani S; Iman M; Azimzadeh Jamalkandi S
Expert Opin Biol Ther; 2015 Feb; 15(2):269-85. PubMed ID: 25399911
[TBL] [Abstract][Full Text] [Related]
32. Designing chemically modified oligonucleotides for targeted gene silencing.
Deleavey GF; Damha MJ
Chem Biol; 2012 Aug; 19(8):937-54. PubMed ID: 22921062
[TBL] [Abstract][Full Text] [Related]
33. Liver as a target for oligonucleotide therapeutics.
Sehgal A; Vaishnaw A; Fitzgerald K
J Hepatol; 2013 Dec; 59(6):1354-9. PubMed ID: 23770039
[TBL] [Abstract][Full Text] [Related]
34. Signaling pathways for tumor necrosis factor-alpha and interleukin-6 expression in human macrophages exposed to titanium-alloy particulate debris in vitro.
Nakashima Y; Sun DH; Trindade MC; Maloney WJ; Goodman SB; Schurman DJ; Smith RL
J Bone Joint Surg Am; 1999 May; 81(5):603-15. PubMed ID: 10360689
[TBL] [Abstract][Full Text] [Related]
35. siRNAs: mechanism of RNA interference, in vivo and potential clinical applications.
Karagiannis TC; El-Osta A
Cancer Biol Ther; 2004 Nov; 3(11):1069-74. PubMed ID: 15539939
[TBL] [Abstract][Full Text] [Related]
36. RNA INTERFERENCE: NEW APPROACH TO THE TREATMENT OF ALLERGIC ASTHMA (A REVIEW).
Shilovskii IP; Prozorova MS; Gaisina AR; Laskin AA; Smirnov VV; Babakhin AA; Khaitov MR
Eksp Klin Farmakol; 2016 Aug; 79(4):35-44. PubMed ID: 29949702
[TBL] [Abstract][Full Text] [Related]
37. Abrogation of the Fc gamma receptor IIA-mediated phagocytic signal by stem-loop Syk antisense oligonucleotides.
Matsuda M; Park JG; Wang DC; Hunter S; Chien P; Schreiber AD
Mol Biol Cell; 1996 Jul; 7(7):1095-106. PubMed ID: 8862523
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA regulation of allergic inflammation and asthma.
Pua HH; Ansel KM
Curr Opin Immunol; 2015 Oct; 36():101-8. PubMed ID: 26253882
[TBL] [Abstract][Full Text] [Related]
39. Treatment of allergic asthma by targeting transcription factors using nucleic-acid based technologies.
Sel S; Henke W; Dietrich A; Herz U; Renz H
Curr Pharm Des; 2006; 12(25):3293-304. PubMed ID: 17020535
[TBL] [Abstract][Full Text] [Related]
40. Receptor-interacting protein 2 gene silencing attenuates allergic airway inflammation.
Goh FY; Cook KL; Upton N; Tao L; Lah LC; Leung BP; Wong WS
J Immunol; 2013 Sep; 191(5):2691-9. PubMed ID: 23918989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
